Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azithromycin + Chloroquine vs Chloroquine for Asymptomatic P. falciparum
NCT00082563Phase 2Terminated
- Sponsor
- Pfizer
- Start
- Aug 2004
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, double-blind trial of azithromycin in Plasmodium falciparum malaria (2 arms), sponsored by Pfizer. Primary endpoint: Parasite clearance. Started Aug 2004; status: terminated.
02
Drugs
azithromycin
03
Conditions
Plasmodium falciparum malaria
Beyond the preview
Go deeper on NCT00082563.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00082563.